| Full text | |
| Author(s): |
Trinconi, Cristiana T.
[1]
;
Reimao, Juliana Q.
[1]
;
Yokoyama-Yasunaka, Jenicer K. U.
[1]
;
Miguel, Danilo C.
[1]
;
Uliana, Silvia R. B.
[1]
Total Authors: 5
|
| Affiliation: | [1] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo - Brazil
Total Affiliations: 1
|
| Document type: | Journal article |
| Source: | Antimicrobial Agents and Chemotherapy; v. 58, n. 5, p. 2608-2613, MAY 2014. |
| Web of Science Citations: | 24 |
| Abstract | |
Leishmaniasis chemotherapy remains very challenging. The high cost of active drugs, along with the severity of their side effects and the increasing failure rate of the current therapeutic schemes, calls for the discovery of new active drugs and schemes of treatment. The use of combination therapy has gained much attention in recent years as a possible strategy for overcoming the various shortcomings in the present arsenal. We recently described the effectiveness of tamoxifen in murine models of leishmaniasis, and here, we investigated the interactions between tamoxifen and amphotericin B, one of the most potent drugs used in leishmaniasis treatment. The in vitro interactions were indifferent for the association of tamoxifen and amphotericin B. The association was also assayed in vivo in Leishmania amazonensis-infected BALB/c mice and was found to yield at least additive effects at low doses of both drugs. (AU) | |
| FAPESP's process: | 11/20484-7 - Tamoxifen in the treatment of leishmaniasis: evaluation of efficacy in combination therapy schemes and study of the antileishmanial mechanism of action |
| Grantee: | Silvia Reni Bortolin Uliana |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 11/18858-6 - TAMOXIFEN AS AN ANTI-LEISHMANIAL DRUG: ACTIVITY IN COMBINED THERAPEUTIC SCHEMES AND STUDY OF THE MECHANISM OF ACTION |
| Grantee: | Cristiana de Melo Trinconi Tronco |
| Support Opportunities: | Scholarships in Brazil - Doctorate |